- 期刊
C57BL/6 and A/J Mice Have Different Inflammatory Response and Liver Lipid Profile in Experimental Alcoholic Liver Disease
延伸閱讀
- Zhu, W., Bao, R., Fan, X., Tao, T., Zhu, J., JiafengWang, Li, J., Bo, L., & Deng, X. (2013). PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model. Mediators of Inflammation, 2013(), 61-67-106. https://doi.org/10.1155/2013/361501
- Willemin, G., Roger, C., Bauduret, A., & Minehira, K. (2013). Major Histocompatibility Class II Pathway Is Not Required for the Development of Nonalcoholic Fatty Liver Disease in Mice. International Journal of Endocrinology, 2013(), 945-956-215. https://doi.org/10.1155/2013/972962
- 鄭婷羽（2015）。Novel Potential Drugs Identification for Liver Lipid Metabolism Modulation by High Content Screening〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2015.02407
- 謝伊晴（2010）。Effects of epidermal growth factor on alcoholic liver disease in rats by improving intestinal permeability〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://doi.org/10.6831/TMU.2010.00127
- Aller, M. A., Vara, E., Garcia, C., Palma, M. D., Arias, J. L., Nava, M. P., & Arias, J. (2005). Proinflammatory Liver and Antiinflammatory Intestinal Mediators Involved in Portal Hypertensive Rats. Mediators of Inflammation, 2005(), 101-111. https://doi.org/10.1155/MI.2005.101